These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6890955)

  • 1. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.
    Hishikawa-Itoh Y; Sugie I; Kato H; Iwanaga S
    J Biochem; 1982 Oct; 92(4):1129-40. PubMed ID: 6890955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1985 Feb; 37(3):465-75. PubMed ID: 3992529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation products.
    Soria J; Soria C; Bertrand O; Dunn F; Samama M; Bachmann F
    Thromb Haemost; 1982 Jun; 47(3):193-6. PubMed ID: 7051407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
    Takada A; Takada Y
    Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
    Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
    Takada Y; Takada A
    Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of SK-potentiator and fibrinogen degradation products on the activation of human plasminogen by streptokinase.
    Takada A; Mochizuki K; Takada Y
    Thromb Res; 1981 Jun 1-25; 22(5-6):623-31. PubMed ID: 7197815
    [No Abstract]   [Full Text] [Related]  

  • 8. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
    Krajewski T; Nowak P; Cierniewski C
    Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y; Takada A
    Thromb Res; 1989 Apr; 54(2):133-9. PubMed ID: 2526391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resistance of fibrinogen and soluble fibrin monomer in blood to degradation by a potent plasminogen activator derived from cadaver limbs.
    Gurewich V; Hyde E; Lipinski B
    Blood; 1975 Oct; 46(4):555-65. PubMed ID: 126095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Glu-plasminogen by urokinase in the presence of fibrinogen, fibrin, and SK-potentiator.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):497-501. PubMed ID: 6457416
    [No Abstract]   [Full Text] [Related]  

  • 12. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on SK-potentiator of plasminogen in human plasma.
    Takada A; Takada Y
    Thromb Res; 1978 Sep; 13(3):325-35. PubMed ID: 741429
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
    Regañon E; Aznar J; Vila V
    Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.
    Takada A; Takada Y; Sugawara Y
    Haemostasis; 1988; 18(2):106-12. PubMed ID: 3410360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.
    Gram J; Jespersen J
    Thromb Haemost; 1985 Apr; 53(2):255-9. PubMed ID: 4024036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization SK-potentiators of plasminogen.
    Takada A; Mochizuki K; Takada Y
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):485-92. PubMed ID: 6160641
    [No Abstract]   [Full Text] [Related]  

  • 18. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN; Cederholm-Williams SA; Allington MJ; Sharp AA
    Thromb Res; 1977 Mar; 10(3):421-30. PubMed ID: 854878
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.